E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy

被引：41
|
作者：
Claudiani, Simone [1 ]
Apperley, Jane F. [1 ]
Gale, Robert Peter [1 ]
Clark, Richard [2 ]
Szydlo, Richard [1 ]
Deplano, Simona [1 ]
Palanicawandar, Renuka [1 ]
Khorashad, Jamshid [1 ]
Foroni, Letizia [1 ]
Milojkovic, Dragana [1 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Haematol, London, England
[2] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
来源：
HAEMATOLOGICA | 2017年 / 102卷 / 08期
关键词：
CHRONIC MYELOGENOUS LEUKEMIA; MOLECULAR RESPONSE; YOUNG-ADULTS; IMATINIB; E13A2; TRIAL;
D O I：
10.3324/haematol.2017.168740
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E297 / E299
页数：3
相关论文
共 50 条
  • [41] A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment
    Ureshino, Hiroshi
    Takeda, Yusuke
    Kamachi, Kazuharu
    Ono, Takaaki
    Iriyama, Noriyoshi
    Ohtsuka, Eiichi
    Sakaida, Emiko
    Kimura, Shinya
    CLINICS AND PRACTICE, 2024, 14 (04) : 1216 - 1224
  • [42] Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission
    Ruth Stuckey
    Juan Francisco López Rodríguez
    María Teresa Gómez-Casares
    Current Oncology Reports, 2022, 24 : 415 - 426
  • [43] Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells
    Tsubaki, Masanobu
    Takeda, Tomoya
    Matsuda, Takuya
    Kimura, Akihiro
    Tanaka, Remi
    Nagayoshi, Sakiko
    Hoshida, Tadafumi
    Tanabe, Kazufumi
    Nishida, Shozo
    BMB REPORTS, 2023, 56 (02) : 78 - 83
  • [44] MOLECULAR RESPONSE TO THERAPY WITH TYROSINE KINASE INHIBITORS IN PATIENTS WITH BCR-ABL1(+) CHRONIC MYELOID LEUKEMIA PRESENTING WITH AN ISOLATED THROMBOCYTOSIS AT THE ONSET
    Balatzenko, G.
    Hrischev, V.
    Ignatova, K.
    Stoyanova, Z.
    Lilova, A.
    Angelova, S.
    Ivanova, S.
    Romanova, M.
    Ivanova, I.
    Tsvetkova, G.
    Hadjiev, E.
    Madzharova, V.
    Dikov, T.
    Spassov, B.
    Davidkova, Y.
    Jagurinoski, M.
    Guenova, M.
    HAEMATOLOGICA, 2017, 102 : 733 - 733
  • [45] CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH E14A2 BCR-ABL FUSION TRANSCRIPT ACHIEVE A FASTER MAJOR MOLECULAR REMISSION (MMR) ON IMATINIB THAN THOSE EXPRESSING THE E13A2 TRANSCRIPT
    Hanfstein, B.
    Erben, P.
    Agrawal, M.
    Schnittger, S.
    Schenk, T.
    Ernst, T.
    Hofmann, W. K.
    Hehlmann, R.
    Hochhaus, A.
    Mueller, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 337 - 337
  • [46] Assessment of BCR-ABL1 transcript levels at 3 months is the major determinant for outcome in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
    Katalinic, D.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S100 - S100
  • [47] Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study
    Aleem, Aamer
    Alqahtani, Farjah
    Jamal, Ahmed
    Alkhudair, Nora A.
    Alghafis, Mashail
    Siti, Hajar Wan Zuki
    Alahmari, Bader
    Salama, Hend
    Gmati, Giamal Edin
    Alzahrani, Mohsen
    Alhejazi, Ayman
    Shaheen, Naila A.
    Alrajhi, Abdullah M.
    Alfayez, Mansour
    Iqbal, Zafar
    Alaskar, Ahmed
    BLOOD, 2022, 140 : 12220 - 12221
  • [48] Identification of a Novel BCR-ABL1 Fusion Transcript in a Chronic Myeloid Leukemia (CML) Patient By Unique Molecular Methods and Subsequent Monitoring of the Patient's Response to Tyrosine Kinase Inhibitor (TKI) Therapy
    Dash, Durga Prasad
    Trap-stamborski, Valerie
    Czajkowski, Curt
    Rauscher, Daniel
    Pillai, Raju
    BLOOD, 2018, 132
  • [49] Extramedullary blast crisis as initial presentation in chronic myeloid leukemia with the e1a2 BCR-ABL1 transcript: A case report
    Ai, Di
    Liu, Wei
    Lu, Gary
    Patel, Keyur Pravinchandra
    Chen, Zi
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (06) : 1319 - 1322
  • [50] Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study
    Su, Yi-Jiun
    Kuo, Ming-Chung
    Teng, Chieh-Lin
    Chen, Tsai-Yun
    Ma, Ming-Chun
    Hsiao, Pei-Ching
    Wang, Ming-Chung
    Lin, Tung-Huei
    Hwang, Wen-Li
    Chen, Chih-Cheng
    Yang, Youngsen
    Pei, Sung-Nan
    Huang, Yen-Min
    Li, Sin-Syue
    Lee, Ming-Yang
    Cheng, Hung-I
    Shih, Lee-Yung
    BLOOD, 2017, 130
12345